<DOC>
	<DOCNO>NCT00752882</DOCNO>
	<brief_summary>Meningitis infection morbidity mortality depend delay initial treatment good prognostic . The antibiotherapy rapidity allow decrease mortality . Intermittent administration ceftazidime reference treatment Pseudomonas aeruginosa meningitis . In case Pseudomonas aeruginosa pneumopathy , ceftazidime administer intermittent injection continuous perfusion . The continuous administration ceftazidime validate Pseudomonas aeruginosa meningitis . However , ceftazidime time dependant antibiotic continuous treatment would provide efficient therapeutic . The aim study determine continuous administration ceftazidime could permit good therapeutic practice Pseudomonas aeruginosa meningitis compare intermittent administration .</brief_summary>
	<brief_title>Ceftazidime Pharmacokinetic Cerebrospinal Fluid Between Continuous Intermittent Administration</brief_title>
	<detailed_description>This study compare administration ceftazidime intermittent intravenous injection ( 29 mg/kg 30min Ã—3/day ) continuous infusion ( 86 mg/kg/24 h , precede 29 mg/kg/30 min ) . The main evaluation criterion study measure time ceftazidime concentration minimal inhibitive concentration Pseudomonas aeruginosa cerebrospinal fluid . This study develop neurological intensive care department . Inclusion criterion essentially , patient age 18 year old , hospitalised cerebrolesion associate hydrocephalus drain external ventricular derivation , acquire pneumopathy mechanic ventilation since 7 day department neurological intensive care . This study prospective randomise , simple blind divide two part . The first part study study parallel group compare treatment initiation continuous intermittent treatment ceftazidime . The second part study cross-over study . One patient group receive continuous treatment ceftazidime patient group receive intermittent treatment ceftazidime .</detailed_description>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Pseudomonas Infections</mesh_term>
	<mesh_term>Ceftazidime</mesh_term>
	<criteria>patient age 18 year old , patient hospitalise cerebrolesion associate hydrocephalus drain external ventricular derivation , acquire pneumopathy mechanic ventilation since 7 day department neurological intensive care patient treat ceftazidime 15 day begin study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Ceftazidime</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pseudomonas</keyword>
	<keyword>aeruginosa</keyword>
	<keyword>Meningitis</keyword>
	<keyword>Patients</keyword>
	<keyword>hospitalise</keyword>
	<keyword>cerebrolesion</keyword>
	<keyword>acquire</keyword>
	<keyword>pneumopathy</keyword>
	<keyword>mechanic</keyword>
	<keyword>ventilation</keyword>
</DOC>